Off-label studies on tofacitinib in dermatology: a review
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Dermatological Treatment"
DOI: 10.1080/09546634.2019.1673877
Abstract: Abstract Purpose Tofacitinib citrate is an oral Janus kinase 1/3 inhibitor approved for rheumatoid arthritis, ulcerative colitis, and active psoriatic arthritis. Tofacitinib is being increasingly used off-label for dermatological conditions, with varying efficacy across recent… read more here.
Keywords: dermatologic conditions; tofacitinib; studies tofacitinib; dermatology ... See more keywords